Answers are grounded in this paper and cite their sources.
Prospective comparative study demonstrates melatonin improves sleep quality in cancer patients, suggesting a better side effect profile than olanzapine.
< 0.001). Melatonin showed statistically significant superiority over olanzapine in PSQI scores at week four and overall AIS scores across all time points; however, melatonin exhibited a more favorable adverse effect profile, while olanzapine was associated with somnolence, akathisia, and weight gain. Both agents are effective for cancer-related insomnia symptoms, with melatonin offering a superior tolerability advantage in the palliative setting. Larger placebo-controlled trials with objective sleep measures are warranted to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Pingoliya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: